BRIEF published on 11/19/2025 at 10:45, 15 days 21 hours ago Shanghai Kehua Bio-engineering Unveils Polaris V150 at MEDICA 2025 MEDICA 2025 Polaris V150 Immunoassay Analyzer Laboratory Efficiency Shanghai Kehua Bio-engineering
BRIEF published on 11/19/2025 at 10:45, 15 days 21 hours ago Shanghai Kehua Bio-engineering dévoile Polaris V150 à MEDICA 2025 MEDICA 2025 Polaris V150 Analyseur D'immunoessais Efficacité Du Laboratoire Shanghai Kehua Bio-ingénierie
PRESS RELEASE published on 11/19/2025 at 10:40, 15 days 21 hours ago KHB Highlights the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer at MEDICA 2025 Shanghai Kehua Bio-engineering showcases Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer at MEDICA 2025, offering compact, high-performance diagnostic solutions for labs MEDICA 2025 Polaris V150 Immunoassay Analyzer Shanghai Kehua Bio-engineering Chemiluminescence
Published on 12/05/2025 at 02:35, 5 hours 33 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 8 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 3 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 8 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour 8 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 38 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 17 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 43 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 53 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 53 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 8 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 8 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 23 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 23 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
